Overall survival at three years
|
Presence of complications |
|
|
|
Yes |
1.80 |
1.16–2.76 |
0.008 |
No |
1 (Reference) |
|
|
Existence of extra hepatic metastases |
|
|
|
Yes |
2.01 |
1.03–3.94 |
0.041 |
No |
1 (Reference) |
|
|
Local recurrence-free survival at three years
|
Maximum size of the lesion |
|
|
|
<1 cm, |
1 (Reference) |
|
0.071 |
1–3 cm |
2.88 |
0.68–12.13 |
0.151 |
≧3 cm |
5.58 |
1.14–27.23 |
0.034 |
Hepatic recurrence-free survival at three years
|
Bilateral liver metastases |
|
|
|
Yes |
2.10 |
1.12–3.89 |
0.019 |
No |
1 (Reference) |
|
|
Presence of complications |
|
|
|
Yes |
1.40 |
1.03–1.90 |
0.035 |
No |
1 (Reference) |
|
|
Number of metastases treated by intra-operative ablation |
|
|
|
≧2 |
1.40 |
1.03–2.00 |
0.033 |
<2 |
1 (Reference) |
|
|
Progression-free survival at three years
|
Synchronous liver metastases |
|
|
|
Yes |
1.57 |
1.12–2.19 |
0.008 |
No |
1 (Reference) |
|
|
Presence of complications |
|
|
|
Yes |
1.40 |
1.05–1.86 |
0.022 |
No |
1 (Reference) |
|
|
Pre-operative targeted therapy |
|
|
|
Yes |
1.41 |
1.05–1.88 |
0.021 |
No |
1 (Reference) |
|
|